StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.19−0.35 (-2.79%)

Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%

Medifast operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Medifast's operating cash flow for the twelve months ending Sep 30, 2026 was -$26.00K, down 100.4% year over year. For fiscal 2025 it was $6.86M, down 72.0% from the year before. Over ten years it grew -13.5% a year on average. The highest annual figure on record is $194.57M in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.86M-72.0%
FY2024Dec 31, 2024$24.48M-83.4%
FY2023Dec 31, 2023$147.66M-24.1%
FY2022Dec 31, 2022$194.57M+105.8%
FY2021Dec 31, 2021$94.55M-34.9%
FY2020Dec 31, 2020$145.20M+72.3%
FY2019Dec 31, 2019$84.26M+38.6%
FY2018Dec 31, 2018$60.82M+40.7%
FY2017Dec 31, 2017$43.24M+70.6%
FY2016Dec 31, 2016$25.35M-13.8%
FY2015Dec 31, 2015$29.41M+15.2%
FY2014Dec 31, 2014$25.54M-39.7%
FY2013Dec 31, 2013$42.36M+5.2%
FY2012Dec 31, 2012$40.26M+15.5%
FY2011Dec 31, 2011$34.87M+21.2%
FY2010Dec 31, 2010$28.77M+50.2%
FY2009Dec 31, 2009$19.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.30M-72.8%
Q2 FY2026Jun 30, 2026$1.70M–
Q1 FY2026Mar 31, 2026$260.00K-92.4%
Q4 FY2025Dec 31, 2025-$5.28M–
Q3 FY2025Sep 30, 2025$12.11M+33.5%
Q2 FY2025Jun 30, 2025-$3.38M-125.8%
Q1 FY2025Mar 31, 2025$3.41M-53.2%
Q4 FY2024Dec 31, 2024-$4.95M-147.0%
Q3 FY2024Sep 30, 2024$9.07M-69.7%
Q2 FY2024Jun 30, 2024$13.07M-69.7%
Q1 FY2024Mar 31, 2024$7.28M-88.6%
Q4 FY2023Dec 31, 2023$10.52M-79.7%
Q3 FY2023Sep 30, 2023$29.93M-46.0%
Q2 FY2023Jun 30, 2023$43.15M-1.4%
Q1 FY2023Mar 31, 2023$64.06M+46.7%
Q4 FY2022Dec 31, 2022$51.74M–
Q3 FY2022Sep 30, 2022$55.40M+250.6%
Q2 FY2022Jun 30, 2022$43.76M+109.6%
Q1 FY2022Mar 31, 2022$43.67M-33.1%
Q4 FY2021Dec 31, 2021-$7.46M-137.6%
Q3 FY2021Sep 30, 2021$15.80M-61.6%
Q2 FY2021Jun 30, 2021$20.88M-63.7%
Q1 FY2021Mar 31, 2021$65.33M+144.3%
Q4 FY2020Dec 31, 2020$19.83M+3.5%
Q3 FY2020Sep 30, 2020$41.11M+129.7%
Q2 FY2020Jun 30, 2020$57.52M+297.3%
Q1 FY2020Mar 31, 2020$26.74M-18.3%
Q4 FY2019Dec 31, 2019$19.15M+24.9%
Q3 FY2019Sep 30, 2019$17.90M+157.6%
Q2 FY2019Jun 30, 2019$14.48M-29.5%
Q1 FY2019Mar 31, 2019$32.73M+81.8%
Q4 FY2018Dec 31, 2018$15.34M+53.6%
Q3 FY2018Sep 30, 2018$6.95M-44.4%
Q2 FY2018Jun 30, 2018$20.52M+45.9%
Q1 FY2018Mar 31, 2018$18.01M+169.5%
Q4 FY2017Dec 31, 2017$9.98M–
Q3 FY2017Sep 30, 2017$12.51M–
Q2 FY2017Jun 30, 2017$14.07M–
Q1 FY2017Mar 31, 2017$6.68M–
Q4 FY2016Dec 31, 2016-$315.00K–

More Medifast figures

See a number that looks wrong?